Product Review - Subcutaneous methotrexate injection in RA

This review discusses the evidence in support of the use of subcutaneous methotrexate, its pharmacology, and efficacy and tolerability as demonstrated in pivotal clinical trials. It also provides commentary and recommendations from Phillip Vecchio who is Director of Rheumatology at the Princess Alexandra Hospital, Brisbane.

 

Please login below to download this issue (PDF)

Subscribe